Amgen Inc (AMGN)
271.91
+2.98
(+1.11%)
USD |
NASDAQ |
Apr 22, 16:00
271.91
0.00 (0.00%)
Pre-Market: 08:39
Amgen Cash from Investing (Quarterly): -27.09B for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -27.09B |
| September 30, 2023 | -262.00M |
| June 30, 2023 | -211.00M |
| March 31, 2023 | 1.358B |
| December 31, 2022 | -3.473B |
| September 30, 2022 | -267.00M |
| June 30, 2022 | -2.193B |
| March 31, 2022 | -111.00M |
| December 31, 2021 | -230.00M |
| September 30, 2021 | 73.00M |
| June 30, 2021 | 1.209B |
| March 31, 2021 | -319.00M |
| December 31, 2020 | -1.384B |
| September 30, 2020 | -1.628B |
| June 30, 2020 | -2.159B |
| March 31, 2020 | -230.00M |
| December 31, 2019 | -5.963B |
| September 30, 2019 | 5.372B |
| June 30, 2019 | 2.745B |
| March 31, 2019 | 3.555B |
| December 31, 2018 | -4.637B |
| September 30, 2018 | 1.132B |
| June 30, 2018 | 2.938B |
| March 31, 2018 | 14.91B |
| December 31, 2017 | -78.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.976B |
| June 30, 2017 | -1.813B |
| March 31, 2017 | -157.00M |
| December 31, 2016 | -1.222B |
| September 30, 2016 | -2.389B |
| June 30, 2016 | -657.00M |
| March 31, 2016 | -4.39B |
| December 31, 2015 | -233.00M |
| September 30, 2015 | -2.003B |
| June 30, 2015 | -2.359B |
| March 31, 2015 | -952.00M |
| December 31, 2014 | 374.00M |
| September 30, 2014 | -2.903B |
| June 30, 2014 | -2.458B |
| March 31, 2014 | -765.00M |
| December 31, 2013 | -10.12B |
| September 30, 2013 | -2.119B |
| June 30, 2013 | 1.959B |
| March 31, 2013 | 1.809B |
| December 31, 2012 | -2.031B |
| September 30, 2012 | -3.173B |
| June 30, 2012 | -2.44B |
| March 31, 2012 | -2.346B |
| December 31, 2011 | -220.00M |
| September 30, 2011 | -857.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-27.09B
Minimum
Dec 2023
5.372B
Maximum
Sep 2019
-1.830B
Average
-262.00M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Gilead Sciences Inc | -727.00M |
| Johnson & Johnson | -1.202B |
| Eli Lilly and Co | -2.924B |
| Merck & Co Inc | 53.00M |
| Vertex Pharmaceuticals Inc | -886.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 538.00M |
| Cash from Financing (Quarterly) | 2.754B |
| Free Cash Flow | 7.359B |
| Free Cash Flow Per Share (Quarterly) | 0.5372 |
| Free Cash Flow to Equity (Quarterly) | -3.856B |
| Free Cash Flow to Firm (Quarterly) | 1.028B |
| Free Cash Flow Yield | 5.03% |